Special Notice of GSA purchase with Non-GSA items (75F40126Q132980).pdf

SPECIAL NOTICE: NOTICE OF INTENT TO INCORPORATE NON-MAS (“OPEN

MARKET”) ITEMS OVER $20k ON GSA FEDERAL SUPPLY SCHEDULE (FSS) Blanket Purchase Agreement (BPA)

Solicitation/BPA Number: 75F40126Q132980 Target Awardee: AB SCIEX LLC Classification Code: 6640 – Laboratory Equipment and Supplies NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing

The purpose of this notification is to meet the public dissemination requirement under FAR 5.101(a) to publicize a proposed contract action expected to exceed $20,000 for Non-MAS components incorporated into a Federal Supply Schedule Blanket Purchase Agreement (BPA).

1. Notice Purpose and Authority

The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), hereby issues this Special Notice. The Government intends to establish a single-award Blanket Purchase Agreement (BPA) with an estimated total maximum ceiling value of $9,500,000.00 utilizing GSA Federal Supply Schedule procurement procedures in accordance with FAR 8.401 for the purchase of Sciex Liquid Chromatography-Mass Spectrometers (LC-MS/MS) instrument systems – specifically, triple quadrupole MS (QqQ) instruments, Ultra High-Performance Liquid Chromatography (UHPLC) instruments, High Performance Liquid Chromatography (HPLC) systems, wide-range diode array detectors, and nitrogen generator (NG) units. This public notice satisfies the statutory requirement to synopsize the incidental, non-Schedule components greater than $20,000.00 that are anticipated for incorporation into the upcoming BPA framework, which will be anchored to the Federal Supply Schedule contract held by AB Sciex LLC.

2. Disclosure of Non-FSS (Open Market) Components

To deliver a turn-key instrumentation framework that satisfies the FDA’s mission requirement, the Government intends to incorporate a subset of Open Market (Non-FSS) components estimated at a cumulative value of $3,135,000.00 directly into the final BPA structure.

The specific open-market components and manufacturer sub-parts to be incorporated include:

• Configured LC-40 X3 UHPLC System Bundle Base, P/N: 5309374 (Main system stack includes: SIL-40C X3 Autosampler, 2 LC-40D X3 Pumps, SCL-40 Controller, CTO-40C Column Oven, 20 uL Micro Mixer, and DGU-405 Degasser)

• Agilent 1290 Infinity III UHPLC System Base Configuration (Main components include:

1290 High-Speed Pump module, 1290 Multisampler unit, 1290 Multicolumn Thermostat oven, and integrated local controller interface)

• Shimadzu 40X3 Compatible Diode Array Detector (DAD) Upgrade, P/N: SPD-M40

• SCIEX ExionLC AE Compatible Diode Array Detector (DAD) Upgrade, P/N: EX-

DAD

• Agilent 1290 Infinity III Compatible Diode Array Detector, P/N: G7115B

• Agilent 1260 Infinity II Diode Array Detector, P/N: EXP-US1-2092

• Photodiode Array Detector SPD-M40 Module, P/N: 5079257

• Semi-Micro Temperature-Controlled Cell for SPD-M40 PDA, P/N: 228-64725-41

• ExionLC AE High-Pressure Solvent Selection Add-On Kit G, P/N: 5312063

• Autosampler External Needle Solvent Multi-Rinse Option Module, P/N: 228-71767-

• Nexera LC-40 Two-Solvent Reservoir Switching Control Valve, P/N: 5309488

• Agilent 1290 Infinity III High-Pressure Column Switching Valve Kit, P/N: 5067-4282

• Agilent Infinity III Handheld Lab Advisor Interface Terminal Upgrade, P/N:

G7108B

• Peak Universal Dual Tap Transformer, P/N: 5323061

• SCIEX OS Acquisition, Qual, and Quant Workstation Software E-License, P/N:

5307946

• Turbo V Source High-Temperature ESI/APCI Exchangeable APCI Probe, P/N:

5309553

• Mass Spec XE5 Win 11 Cyber-Secure Data Acquisition PC Workstation, P/N: 5322513

• Integrated PC Memory Upgrade Surcharge, P/N: MEMORY SURCHARGE

• Standalone 24-Inch Anti-Glare LED Computer Monitor (P2425H), P/N: 5309533

• Success Plus Personalized On-Site Applications Hub Operator Training, P/N:

TRNLP002

• 3-Day Technical Introduction to Triple Quad Course at Sciex Facility, P/N:

TRN00115 OS

• Microsoft Office 2021 Professional Plus LTSC Operating Key, P/N: 5300238

• 10/100 Ethernet Switch Shimadzu, P/N: 4465786 or equal

• Vial Plate 1.5 mL Autosampler Accessory, P/N: 5079897 or equal

• AC Power Cord Set, P/N: 4425944 or equal

• Network Interconnect Shielded Data Cable, P/N: 5074348 or equal

• Network Monochrome Laser Printer Accessory, P/N: EXP-US1-3112 or equal

• Heavy-Duty Laboratory Power Protection Backup Terminal, P/N: 5076232 or equal

• Eaton 9PXM 12-Slot Chassis Uninterruptible Power Supply (6kVA UPS), P/N:

5313639

• LC Installation, Setup, and Multi-Point Calibration, P/N: SV000025

• Additional Scheduled Preventive Maintenance Visit, P/N: ABSX ADDITIONAL PM (Satisfies the FDA’s requirement for a PM during the warranty period)

In compliance with the regulations governing Federal Supply Schedule modifications under FAR 8.401, the Contracting Officer provides the following disclosures:

• Incidental Nature: All open-market items included under this BPA are ancillary and incidental to the primary Federal Supply Schedule equipment and software streams.

• Full Regulatory Compliance: All applicable acquisition regulations pertaining to the purchase of commercial items not on a Federal Supply Schedule are being strictly followed for this component subset, including the public synopsis requirements of RFO 5.101(a) and commercial contracting methods under FAR Part 12.

• Price Reasonableness Verification: Prior to the final execution of the BPA, the prices of the open-market components will be evaluated, and a formal determination of price reasonableness will be certified by the Contracting Officer based on competitive commercial market analyses.

• Administrative Efficiency: The consolidation of these open-market items within the primary GSA FSS vehicle provides a logistical and financial cost-savings benefit to the Government. This single-vehicle approach eliminates duplicate procurement cycles, reduces contract administration overhead, and ensures native system compatibility across the laboratory network.

• Source Labeling: All non-Schedule items will be clearly and explicitly labeled as individual open-market line items upon final award, and all mandatory commercial contract clauses applicable to open-market supplies will be incorporated into the final order.

3. Administrative Instructions

This is a Special Notice published for information and transparency purposes only. This announcement does not constitute a request for competitive open-market quotations, and a separate open-market solicitation will not be issued.

Interested parties possessing inquiries regarding this notice may contact the Contracting Officer, Suzanne Martella, via email at suzanne.martella@fda.hhs.gov no later than 09/24/2026 at 09:00 AM Central time.

mailto:suzanne.martella@fda.hhs.gov